Logo_Horizontal_Fill_White_Transparent.png
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
11 juin 2024 16h05 HE | Neurona Therapeutics
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
Allyx.jpg
Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001
11 juin 2024 08h00 HE | Allyx Therapeutics Inc.
Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001.
Logo_Horizontal_Fill_White_Transparent.png
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
28 mai 2024 08h00 HE | Neurona Therapeutics
Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
UAA.png
UsAgainstAlzheimer’s Launches 2024 Brain Health Academy
16 avr. 2024 10h48 HE | UsAgainstAlzheimer's
WASHINGTON, April 16, 2024 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s today announced the return of its Brain Health Academy, scheduled to begin on May 9, 2024. First launched in 2022, the Academy...
UAA.png
Congress Passes Bills Making Major Investments in Alzheimer’s
23 mars 2024 10h15 HE | UsAgainstAlzheimer's
Congress passes major investments in the fight against Alzheimer’s.
Allyx.jpg
Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients
11 mars 2024 08h05 HE | Allyx Therapeutics Inc.
Allyx Therapeutics Announces Positive Phase 1b Multiple Ascending Dose Data and Advances ALX-001 to Patients
UAA.png
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s
08 mars 2024 07h55 HE | UsAgainstAlzheimer's
WASHINGTON, March 08, 2024 (GLOBE NEWSWIRE) -- The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the...
Global Neurological Biomarkers Market
Global Neurological Biomarkers Market Analysis Report 2024-2030 - CAGR of 12.8% - Increased Funding For R&D in Biomarkers to Boost Development of New Drugs
24 janv. 2024 05h40 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism),...
For people living wi
For people living with dementia, support changes everything. The Alzheimer Society connects Albertans to dementia-friendly support, knowledge, and community.
02 janv. 2024 13h17 HE | Alzheimer Society of Alberta and NWT
Edmonton, Jan. 02, 2024 (GLOBE NEWSWIRE) -- A diagnosis of dementia is not easy. During National Alzheimer’s Awareness Month in January, the ALZHEIMER SOCIETY OF ALBERTA AND NORTHWEST TERRITORIES...
tiziana-logo.png
Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar
04 déc. 2023 07h09 HE | Tiziana Life Sciences Ltd.
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...